Procedures
Hyperbaric Oxygen Therapy
Background
- Hyperbaric Oxygen Therapy (HBOT) can treat a wide range of health problems
- Hyperoxia (View image)
- Restores neutrophil O2-mediated bacterial killing
- Bactericidal for anaerobes and bacteriostatic for species of E. coli, Pseudomonas
- Suppresses Clostridial production of alpha toxin
- Stimulates angiogenesis
- Inhibits many parts of reperfusion injury cascade, reduces local edema
- Carbon-monoxide mediated brain lipid peroxidation
- May also reduce neurologic sequelae after acute CO poisoning (controversial)
- Treatment guidelines
- Guidance
- Patient breathes 100% O2 intermittently inside treatment chamber > sea level pressure (i.e., > 1 atm)
- Pressurization should be ≥ 1.4 atm absolute (abs) to be considered HBOT
- Medications recommended to be discontinued before treatment
- Bleomycin ⇒ interstitial pneumonias
- Sulfamylon ⇒ impairs wound healing
- Cisplatin ⇒ impairs wound healing
- Disulfiram ⇒ increases risk for O2 toxicity
- Doxorubicin ⇒ cardiotoxicity
Indications
- Hyperbaric Medical Society Hyperbaric Oxygen Therapy Indications (15th ed.)
- Air or gas embolism (iatrogenic or diving related)
- Central retinal artery occlusion
- CO poisoning
- Clostridial myonecrosis (gas gangrene)
- Compromised surgical grafts and flaps
- Crush injuries/skeletal muscle compartment syndrome/acute arterial insufficiency
- Decompression sickness
- Intracranial abscess
- Necrotizing soft tissue infections
- Significant blood loss anemia
- Specific acute thermal burns
- Idiopathic sudden sensorineural hearing loss (urgent)
- Delayed radiation injuries for soft tissue or bony necrosis/osteoradionecrosis
- Chronic refractory osteomyelitis
- Enhancement of healing in a problematic wound (diabetic foot ulcers Wagner grade 3-5)
- FDA clearance
- As of July 2021, the FDA has cleared HBOT for the following disorders:
- Air and gas bubbles in blood vessels
- Anemia (severe anemia when blood transfusions cannot be used)
- Burns (severe and large burns treated at a specialized burn center)
- Carbon monoxide poisoning
- Crush injury
- Decompression sickness (diving risk)
- Gas gangrene
- Hearing loss (complete hearing loss that occurs suddenly and without any known cause)
- Infection of the skin and bone (severe)
- Radiation injury
- Skin graft flap at risk of tissue death
- Vision loss (when sudden and painless in one eye due to blockage of blood flow)
- Wounds (non-healing, diabetic foot ulcers)
- HBOT and COVID-19
- HBOT can improve the quality of life, quality of sleep, psychiatric and pain symptoms of patients suffering from long COVID
- The clinical improvements gained by HBOT are persistent even 1 year after the last HBOT session
Contraindications
- Absolute contraindications
- Relative contraindications
- Uncontrolled HTN
- BP can increase during treatment
- DM with glucose > 300 or < 100
- CHF with EF < 35%
- Hyperbaric can exacerbate CHF and/or flash pulmonary edema
- Claustrophobia/confinement anxiety
- May require multiplace chamber or pharmacotherapy (View image)
- Congenital spherocytosis
- Hyperbaric oxygen can cause severe hemolysis
- Current URI
- Concern for ability to equalize on the descent
- Risk of reverse sinus block on the ascent
- Can lead to barotrauma
- Fever
- Lowers seizure threshold during treatment
- Chronic sinus condition
- Concern for ability to equalize on the descent
- Risk of reverse sinus block on the ascent
- Can lead to barotrauma
- Pacemaker/implantable device
- Risk of malfunction under pressure
- If device delivers shock in 100% oxygen environment could ignite a fire
- Coordinate with safety officer and call manufacturer
- Device should be pressure tested
- Recent eye/retinal/cataract surgery or optic neuritis
- Buckle procedure can have air trapped
- Other procedures can leave bubbles inside
- Usually require a few months waiting period before initiation of treatment
- Recent thoracic surgery
- Recommend imaging to rule out pneumothorax
- Obstructive lung disease/chronic obstructive pulmonary disease
- COPD)/asthma ⇒ lose hypoxic drive to breathe
- Screen with PFTs and xenon washout study to evaluate for risk of air trapping
- History of seizures
- Recommend seizures be controlled before initiation of treatment
- Monitor therapeutic levels
- May require lower treatment pressures
- Untreated cancer
- No studies show hyperbarics promote malignant cell proliferation
- Contact lenses
- Need to be gas permeable
- No hard contact lenses
Procedure
- Fill balloon-filled equipment/devices (e.g., Foley, ET tube) with fluid to avoid rupture
- Pretreat with decongestants if sinus congestion present
- Avoid with severe peripheral vascular disease because of vasoconstrictive effects
- May need emergent myringotomy or tympanostomy tubes if high-grade barotrauma (blood, severe erythema, pain) occurs
- Diabetics should receive pre- and post- compression blood sugar checks, since HBO2 can induce hypoglycemia
- Pre-treat 30 min prior to HBO2 with lorazepam or diazepam for confinement anxiety
- Wedge pillow in monoplace chamber: to reduce pulmonary blood flow and risk of pulmonary edema in class patients at high risk for CHF
- Cardiac monitoring for patients with active CAD or hypotension
- Those at risk for seizures should have anticonvulsant levels checked and an IV for rapid administration of anticonvulsants
Complications
- Most are benign and resolve with discontinuation of HBOT
- Effects of Pressure
- Barotrauma (e.g., hyperemia of tympanic membrane, rupture of TM, etc.)
- Sinus pain
- Bronchospasms
- Alveolar rupture
- Damage to devices and prostheses
- Oxygen Toxicity
- Tracheobronchitis
- Tunnel vision
- Tinnitus
- Nausea
- Fasciculations
- Irritability
- Dizziness
- Generalized tonic-clonic seizure
- Retinopathy of prematurity
- Cataract formation
- Transient myopic change in vision
References
- FDA. Hyperbaric Oxygen Therapy: Get the Facts. Available at: https://www.fda.gov/consumers/consumer-updates/hyperbaric-oxygen-therapy-get-facts. [Accessed November 2024]
- In: Huang ET (eds). UHMS Hyperbaric Medicine Indications Manual, 15th ed., Best Publishing Co, Undersea and Hyperbaric Medical Society, 2023
- Hadanny A, Zilberman-Itskovich S, et al. Long term outcomes of hyperbaric oxygen therapy in post covid condition: longitudinal follow-up of a randomized controlled trial. Sci Rep. Feb 15, 2024; 14(3604): https://doi.org/10.1038/s41598-024-53091-3
- Robbins T, Gonevski M, et al. Hyperbaric oxygen therapy for the treatment of long COVID: early evaluation of a highly promising intervention. Clin Med (Lond). Nov 2021;21(6):e629-e632
- Sharma R, Sharma SK, et al. Efficacy of hyperbaric oxygen therapy for diabetic foot ulcer, a systematic review and meta-analysis of controlled clinical trials. Sci Rep. Jan 26, 2021; 11(2189): https://doi.org/10.1038/s41598-021-81886-1
- Edwards M, Cooper JS. Hyperbaric Treatment of Thermal Burns. StatPearls [Internet]. Available at: https://www.ncbi.nlm.nih.gov/books/NBK470524/. [Accessed November 2024]
- Buboltz JB, Robins M. Hyperbaric Treatment of Carbon Monoxide Toxicity. StatPearls [Internet]. Available at: https://www.ncbi.nlm.nih.gov/books/NBK470531/. [Accessed November 2024]
- Weaver LK, Hopkins RO, et al. Hyperbaric Oxygen for Acute Carbon Monoxide Poisoning. N Engl J Med. Oct 3, 2002; 347: 1057-1067
- Moon RE. Hyperbaric oxygen treatment for decompression sickness. Undersea Hyperb Med. Mar-Apr 2014;41(2):151-7
- Shah J. Hyperbaric Oxygen Therapy. J Am Col Certif Wound Spec. Apr 24, 2010;2(1):9-13
- DuBose KJ, Cooper JS. Hyperbaric Patient Selection. StatPearls [Internet]. Available at: https://www.ncbi.nlm.nih.gov/books/NBK499820/. [Accessed November 2024]
- Sadri RA, Cooper JS. Hyperbaric Complications. StatPearls [Internet]. Available at: https://www.ncbi.nlm.nih.gov/books/NBK459191/. [Accessed November 2024]
Contributor(s)
- Ho, Nghia, MD
Updated/Reviewed: November 2024